Insulin pump treatment in children and adolescents with type 1 diabetes: Experiences of the German Working Group for Insulin Pump Treatment in Pediatric Patients

Postgraduate Medicine

Volumn 122, Issue 3, 2010, Pages 98-105

  Kapellen, Thomas M ^a   Klinkert, Christoph ^b   Heidtmann, Bettina ^c   Jakisch, Bela ^c   Haberland, Holger ^d   Hofer, Sabine E ^e   Holl, Reinhard W ^f  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Pediatric diabetologist   (Germany)

^c Catholic Children s Hospital Wilhemstift   (Germany)

^d Children's Hospital Lindenhof   (Germany)

^e Hospital for Children I   (Austria)

^f UNIVERSITY OF ULM   (Germany)

Author keywords

Adolescents; Analog insulin; Children; Long acting analog; Short acting analog; Type 1 diabetes mellitus

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

AGE; CONTINUOUS INFUSION; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; GERMANY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; PATIENT COMPLIANCE; REVIEW; UNITED STATES; ADOLESCENT; CHILD; INSULIN INFUSION; INTRADERMAL DRUG ADMINISTRATION; PRESCHOOL CHILD;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; GERMANY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS;

EID: 77953086574     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.05.2147     Document Type: Review

References (27)

1. Rosenbauer J, Icks A, Giani G. Incidence and prevalence of childhood type 1 diabetes mellitus in Germany-model-based national estimates. J Pediatr Endocrinol Metab. 2002;15(9):1497-1504.
2. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51(12):3353-3361.
3. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type 1 diabetes-the analysis of the data on published incidence trends. Diabetologia. 1999;42(12):1395-1403.
4. Grabert M, Schweiggert F, Holl RW. A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Computer Methods and Programs in Biomedicine. 2002;69(2):115-121.
5. Jakisch BI, Wagner VM, Heidtmann B, et al; German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matchedpair cohort analysis over 3 years. Diabet Med. 2008;25(1):80-85.
6. Paris CA, Imperatore G, Klingensmith G, et al. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study. J Pediatr. 2009;155(2):183-189.
7. Scheiner G, Sobel RJ, Smith DE, et al. Insulin pump therapy: guidelines for successful outcomes. Diabetes Educ. 2009;35(suppl 2):29S-41S.
8. Pankowska E, Blazik M, Dziechiarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs multiple daily injections in children with type 1 diabetes: a systemativc review and metaanalysis of randomized controlled trials. Pediatr Diabetes. 2000;10:52-58.
9. Plank J, Siebenhofer A, Berghold A, et al. Systematic review and meta-analysis of short acting insulin analogues in patients with diabetes mellitus. Arch Intern Med. 2005;165(12):1337-1344.
10. Weintrob N, Benzaquen H, Galatzer A, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics. 2003;112(3 pt 1):559-564.
11. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care. 2003;26(4):1079-1087.
12. Kapellen TM, Heidtmann B, Bachmann J, Ziegler R, Grabert M, Holl RW. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents. Diabet Med. 2007;24(8):836-842.
13. Eugster EA, Francis G; Lawson-Wilkins Drug and Therapeutics Committee. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics. 2006;118(4):e1244-e1249.
14. Kaufman FR, Halvorson M, Carpenter S, Devoe D, Pitukcheewanont P. Insulin pump therapy in young children with diabetes. Diabetes Spectrum. 2001;14:84-89.
15. Rodrigues IA, Reid HA, Ismail K, Amiel SA. Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service. Diabet Med. 2005;22(7):842-849.
16. Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care. 2005;28(6):1277-1281.
17. Mack-Fogg JE, Orlowski CC, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes. 2005:61(1):17-21.
18. Berghaeuser MA, Kapellen T, Heidtmann B, Haberland H, Klinkert C, Holl RW; German working group for insulin pump treatment in paediatric patients. Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria. Pediatr Diabetes. 2008;9(6):590-595.
19. Kapellen TM, Wolf J, Rosenbauer J, et al; DPV-Science-Initiative. Changes in the use of analogue insulins in 37 206 children and adolescents with type 1 diabetes in 275 German and Austrian centres during the last twelve years. Exp Clin Endocrinol Diabetes. 2009;117(7):329-335.
20. Klinkert C, Bachran R Heidtmann B, Grabert M, Holl RW; DPV-Initiative. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes. 2008;116(2):118-122.
21. Danne T, Aman J, Schober E; ANA 1200 Study Group. A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care. 2003;26(8):2359-2364.
22. Danne T, Råstam J, Odendahl R, et al. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes. Pediatr Diabetes. 2007;8(5):278-285.
23. Rutledge KS, Chase P, Klingensmith GJ, Walravens PA, Slover RH, Garg SK. Effectiveness of postprandial Humalog in toddlers with diabetes. Pediatrics. 1997;100(6):968-972.
24. Insulin Pumpers. http://www.insulin-pumpers.org/pkids.shtml. Accessed April 20, 2010.
25. Wood JR, Moreland EC, Volkening LK, Svoren BM, Butler DA, Laffel LMB. Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care. 2006;29(11):2355-2360.
26. Hofer SE, Heidtmann B, Raile K, et al; for the DPV-Science-Initiative and the German working group for insulin pump treatment in pediatric patients. Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria [published online ahead of print June 29, 2009]. Pediatr Diabetes.
27. Barbar GS, Ali O, Parton EA, Hoffmann RG, Alemzadeh R. Factors associated with adherence to continuous subcutaneous insulin infusion with pediatric diabetes. Diabetes Technol Ther. 2009;11(3):131-137.